Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Vnitr Lek ; 68(5): 290-294, 2022.
Article in English | MEDLINE | ID: covidwho-2010607

ABSTRACT

A case report of a patient with newly diagnosed granulomatosis with polyangiitis (GPA) after undergoing COVID-19 (Coronavirus Disease 2019) is discussed. GPA is one of the ANCA-associated vasculitis, which is characterized by the presence of autoantibodies against cytoplasmic enzymes neutrophils (Anti Neutrophil Cytoplasmatic Antibodies). It is a vasculitis that mainly affects small blood vessels, leading to damage to the kidneys, lungs, and upper respiratory tract, including the paranasal sinuses and orbits. This disease can result in an acute life-threatening condition. Such complications include diffuse alveolar hemorrhage (DAH), a condition characterized by blood leakage from the pulmonary vessels into the alveoli, often leading to acute vital signs and even respiratory failure. DAH can have many causes - autoimmune diseases including vasculitides as well as non-immunological causes. Early and adequate comprehensive therapy including immunosuppressive treatment (cyclophosphamide/rituximab and glucocorticoids) can be life-saving.


Subject(s)
COVID-19 , Granulomatosis with Polyangiitis , Lung Diseases , Humans , Granulomatosis with Polyangiitis/complications , Granulomatosis with Polyangiitis/diagnosis , Granulomatosis with Polyangiitis/therapy , COVID-19/complications , Rituximab , Hemorrhage/therapy , Lung Diseases/diagnosis , Lung Diseases/etiology , Lung Diseases/therapy , Antibodies, Antineutrophil Cytoplasmic , Cyclophosphamide/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL